KLOW: GHK-Cu, KPV, BPC-157 and TB-500

Description

KLOW (GHK-Cu + KPV + BPC-157 + TB-500)

Lyophilized Powder | Third-Party Tested | USA-Manufactured

In Stock | Free Shipping on Orders Over $150

---

Product Specifications

• Peptide Name: KLOW Combination Vial
• Molecular Formula: Multi-component peptide blend (see component table below)
• Molecular Weight: Multi-component peptide blend (see component table below)
• CAS Number: 89030-95-5; 67727-97-3; 137525-51-0; 77591-33-4
• Sequence: GHK-Cu (Gly-His-Lys•Cu²⁺); KPV (Lys-Pro-Val); BPC-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val); TB-500 (Thymosin Beta-4 fragment)
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder (combination vial)
• Storage: -20°C (long-term) | 2–8°C (short-term) | Protect from light
• Shelf Life: Up to 12 months when stored sealed and dry

Component	Sequence	Molecular Formula	Molecular Weight	CAS Number
GHK-Cu	Gly-His-Lys•Cu²⁺	C14H24CuN6O4	403.9 g/mol	89030-95-5
KPV	Lys-Pro-Val	C16H30N4O4	342.4 g/mol	67727-97-3
BPC-157	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val	C62H98N16O22	1419.5 g/mol	137525-51-0
TB-500	Thymosin Beta-4 fragment (sequence on file)	C212H350N56O78S	4963 g/mol	77591-33-4

---

Compound Overview

KLOW is a multi-component peptide formulation combining GHK-Cu, KPV, BPC-157, and TB-500 within a single lyophilized vial. Each component possesses a defined amino acid sequence or peptide–metal coordination structure, contributing distinct molecular weights and physicochemical properties relevant to analytical and structural laboratory workflows.

In research settings, KLOW is evaluated for peptide stability profiling, multi-analyte analytical detection, and comparative structural characterization using chromatographic and mass spectrometry methodologies. Experimental literature describes each component within controlled in vitro and preclinical systems examining peptide–metal complexes, short regulatory peptides, and thymosin-derived fragments. All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for KLOW as a research compound.

---

Published Preclinical Research

Published literature describes the individual peptide components of KLOW as defined research compounds investigated within controlled experimental systems.

• Peptide–metal coordination analysis for GHK-Cu complexes
• Short tripeptide characterization and analytical profiling for KPV
• Pentadecapeptide stability and sequence verification studies for BPC-157
• Thymosin-derived fragment identification and analytical detection methodologies for TB-500

All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for KLOW.

---

Research Applications

• Multi-analyte peptide detection and LC-MS method development
• Peptide–metal complex characterization workflows
• Comparative sequence analysis of regulatory peptide fragments
• Chromatographic stability profiling under controlled laboratory conditions
• Analytical validation of combination peptide formulations

---

Physical Specifications

• Vial Size: 10 mL sterile vial
• Fill: 50mg GHK-Cu + 10mg KPV + 10mg BPC-157 + 10mg TB-500
• Appearance: Light blue lyophilized powder
• Reconstitution Volume: Researcher-determined under validated laboratory protocols
• Post-Reconstitution Storage: 2–8°C, use within 30 days
• Solubility: Water-based laboratory solvents

---

Compare to Related Compounds

GLOW (BPC-157 + TB-500 + GHK-Cu)

• KLOW contains four components including KPV, whereas GLOW contains three peptide components without KPV.
• Analytical differentiation is based on total peptide count, molecular composition, and multi-analyte chromatographic profiling.

BPC-157 + TB-500 (5mg/5mg)

• KLOW includes GHK-Cu and KPV in addition to BPC-157 and TB-500, expanding its structural composition compared to the dual-peptide blend.
• Comparative analysis focuses on component complexity, molecular diversity, and analytical validation parameters.

Cartalax

• KLOW is a four-component peptide blend combining GHK-Cu, KPV, BPC-157, and TB-500, whereas Cartalax is a short tripeptide fragment (Ala-Glu-Asp) supplied as a single defined sequence.
• Analytical differentiation is based on formulation complexity, total molecular diversity, and multi-analyte chromatographic profiling compared to a single short peptide structure.

---

Handling & Storage

Lyophilized Stability:
When stored sealed in a dry environment protected from light, lyophilized peptide material may maintain chemical stability for up to 12 months at controlled room temperature. For maximum long-term preservation, storage at -20°C is recommended.

Post-Reconstitution Stability:
Following reconstitution under sterile laboratory conditions, the solution may maintain stability for up to 30 days when stored at 2–8°C. Minimize repeated freeze–thaw cycles and protect from light to preserve peptide integrity.

Handling:
Allow vial to equilibrate to room temperature before opening to prevent moisture condensation. Use sterile technique throughout preparation.

---

Certificate of Analysis & Third-Party Testing

Every batch of BioEdge KLOW undergoes independent third-party testing prior to release. Testing is performed by ISO-accredited laboratories with results available on each product page.

Identity Confirmation	Mass Spectrometry (MS)
Purity Assessment	High-Performance Liquid Chromatography (HPLC)
Minimum Purity Acceptance	≥99%
Heavy Metals	ICP-MS panel
Sterility	USP <71> Sterility Testing
COA Format	Batch-specific test results, downloadable on product page

To view testing results, scroll to the 3rd Party Testing section located below the product image.

---

Why Researchers Choose BioEdge for KLOW

Batch-specific COA from an independent lab. Not a generic PDF recycled across products. Every vial of KLOW is backed by independent third-party laboratory testing, with a Certificate of Analysis available for review on our product page. HPLC confirms purity. Mass spectrometry confirms molecular identity. The COA corresponds to the specific batch you receive.

USA lyophilization. Many vendors import pre-filled vials from overseas and relabel them. BioEdge sources API and performs lyophilization within the United States, maintaining direct quality control over the final product.

No filler compounds. BioEdge KLOW is pure lyophilized peptide blend. No mannitol, no bulking agents, no unnecessary excipients.

Same-day shipping. Domestic orders placed before 3pm ship the same day. Free shipping on orders over $150.

---

Frequently Asked Questions

What is KLOW?

KLOW is a multi-component peptide blend containing GHK-Cu, KPV, BPC-157, and TB-500 supplied exclusively for laboratory research use.

What are the CAS numbers for KLOW components?

89030-95-5; 67727-97-3; 137525-51-0; 77591-33-4

How should KLOW be stored?

Store sealed in a dry environment protected from light. For maximum long-term preservation, storage at -20°C is recommended.

Is KLOW third-party tested?

Yes. Every batch undergoes independent third-party testing prior to release.

Where can I access the COA for KLOW?

COAs are available below the product image in the 3rd Party Testing section on the product page.

Is KLOW FDA approved?

BioEdge KLOW is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use in this form. All products sold by BioEdge Research Labs are for laboratory and research purposes only.

Do you ship KLOW within the USA?

Yes. BioEdge Research Labs is a USA based supplier with same day domestic shipping on orders placed before 3pm Eastern. Free shipping on orders over $150.

Can I get bulk pricing on KLOW?

Yes. Contact BioEdge Research Labs directly for institutional and bulk research pricing.

---

Published References

1. Chang CH, et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” J Applied Physiology. 2011;110(3):774-780. PubMed
2. Philp D, et al. “Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development.” Annals of the New York Academy of Sciences. 2004;1012:44-52. PubMed
3. Park J-R, et al. “The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice.” Oncotarget. 2016;7(36):58405-58417. Link
4. Dalmasso G, et al. “PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation.” Gut. 2008;57(10):1330-1338. Link

---

RESEARCH USE ONLY Disclaimer

RESEARCH USE ONLY. KLOW is sold exclusively for in vitro laboratory and research purposes. This product is not intended for human or animal consumption, clinical use, or therapeutic application. It has not been evaluated by the Food and Drug Administration (FDA) for safety, efficacy, or any medical purpose. Purchase and use of this product confirms the buyer will use it only in qualified research settings, in compliance with all applicable federal, state, and local regulations. BioEdge Research Labs is a chemical supplier, not a compounding pharmacy or clinical facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no claims regarding therapeutic, diagnostic, or clinical applications of this compound.